4/22
08:13 am
cort
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing's Syndrome [Yahoo! Finance]
Low
Report
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing's Syndrome [Yahoo! Finance]
4/22
08:00 am
cort
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
Low
Report
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
4/18
12:15 pm
cort
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
Low
Report
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
4/17
11:00 pm
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
4/17
01:33 pm
cort
Corcept (CORT) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
Low
Report
Corcept (CORT) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
4/16
01:19 pm
cort
Corcept (CORT) Completes Enrollment in Phase II ALS Study [Yahoo! Finance]
Low
Report
Corcept (CORT) Completes Enrollment in Phase II ALS Study [Yahoo! Finance]
4/16
12:30 pm
cort
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
Low
Report
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
4/15
08:13 am
cort
Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) [Yahoo! Finance]
Low
Report
Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) [Yahoo! Finance]
4/15
08:00 am
cort
Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
Low
Report
Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
4/8
08:14 am
cort
Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer [Yahoo! Finance]
Medium
Report
Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer [Yahoo! Finance]
4/8
08:00 am
cort
Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer
Medium
Report
Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer
4/1
08:19 am
cort
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing's Syndrome [Yahoo! Finance]
Low
Report
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing's Syndrome [Yahoo! Finance]
4/1
08:00 am
cort
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome
Low
Report
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome
3/29
07:09 am
cort
Investing in Corcept Therapeutics (NASDAQ:CORT) five years ago would have delivered you a 114% gain [Yahoo! Finance]
Medium
Report
Investing in Corcept Therapeutics (NASDAQ:CORT) five years ago would have delivered you a 114% gain [Yahoo! Finance]
2/24
02:04 am
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
2/19
08:40 am
cort
Corcept Therapeutics: Key Catalysts Ahead [Seeking Alpha]
Low
Report
Corcept Therapeutics: Key Catalysts Ahead [Seeking Alpha]
2/17
08:40 am
cort
Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
2/16
10:03 pm
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
2/16
03:13 pm
cort
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow [Yahoo! Finance]
Neutral
Report
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow [Yahoo! Finance]
2/16
09:21 am
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $36.00 to $42.00. They now have a "buy" rating on the stock.
High
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $36.00 to $42.00. They now have a "buy" rating on the stock.
2/16
09:13 am
cort
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/15
04:55 pm
cort
Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ... [Yahoo! Finance]
Medium
Report
Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ... [Yahoo! Finance]
2/15
04:14 pm
cort
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial [Yahoo! Finance]
Medium
Report
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial [Yahoo! Finance]
2/15
04:14 pm
cort
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update [Yahoo! Finance]
2/15
04:07 pm
cort
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
Medium
Report
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update